Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Laryngeal Neoplasms 3 Head and Neck Neoplasms 3 Uterine Cervical Neoplasms 2 Stomatitis 2 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Hematologic Neoplasms 2 Dyspareunia 2 Carcinoma, Hepatocellular 2 Carcinoma, Basal Cell 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vomiting 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Intraepithelial Lesions 1 Soft Tissue Neoplasms 1 Radiodermatitis 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Pain 1 Ovarian Neoplasms 1 Neoplasms 1 Mucositis 1 HIV Infections 1 Endometrial Neoplasms 1 Eczema 1 Dermatitis 1 Cicatrix 1 Cancer Pain 1

Interventions

Dexamethasone 33 Palonosetron 27 Aprepitant 24 Ondansetron 23 Granisetron 14 Calcium Dobesilate 8 Therapeutics 7 Olanzapine 6 fosaprepitant 5 dexamethasone acetate 5 netupitant, palosentron drug combination 4 casopitant 4 Doxorubicin 4 Cyclophosphamide 4 Acupressure 4 netupitant 3 dolasetron 3 Yoga 3 Tropisetron 3 Surveys and Questionnaires 3 Radiotherapy 3 Metoclopramide 3 Dronabinol 3 Analgesia 3 ramosetron 2 ginger extract 2 dexamethasone 21-phosphate 2 Vincristine 2 Tablets 2 Psychiatric Rehabilitation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Vomiting × Laser Therapy × Clear all

NCT03354741 2026-03-27

NAUVOLA

Centre Hospitalier Universitaire de Nice

Phase NA Completed

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡